Experience
Amarin Pharmaceuticals Ireland Ltd.
Omthera Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals LP
Represented Omthera and AstraZeneca in a non-Hatch-Waxman pharmaceutical patent infringement suit.
Amarin Pharmaceuticals Ireland Ltd. v. Omthera Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals LP, 1:14-cv-00279, D. Del., Judge Sleet
NICE Ltd. et al v. CallMiner Inc.
NICE Ltd. et al
BTG Inc., Ltd v. Actavis Labs FL Inc.; Amneal Pharms LLC
BTG Inc., Ltd.
Valeant Pharm. N. Am. LLC and Kaken Pharm. Co. Ltd. v. Zydus Pharm. (USA) Inc.
Kaken Pharmaceutical Co., Ltd.
AbbVie Inc.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
Aerin Medical Inc. et al. v. Neurent Medical Inc. et al.
Aerin Medical Inc. et al.
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
BioDelivery Sciences International, Inc. et al. v. Chemo Research, SL et al.
BioDelivery Sciences International, Inc. et al.
Zimmer Surgical, Inc. et al. v. Stryker Corporation et al.
Zimmer Surgical, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.